Short Term
Mean Reversion
Neutral
Trend
Neutral
Event
Neutral
Halo Model
MQV
Very Strong
GARP
Very Strong
MQV Small
Neutral
Momentum
Price
Very Weak
Earnings
Very Strong
Growth
Earnings
Very Strong
Dividends
Very Strong
Quality
Capital Efficiency
Very Strong
Balance Sheet
Very Strong
Market Cap
PE
EV/EBITDA
DIV Yield
Franking
Ex Dividend Date (est.)
52 weeks range
Low 0.0 - 0.0
Trade Value (12mth)
N/A
1 week
16.67%
1 month
33.33%
YTD
21.74%
1 year
-15.15%
All time high
N/A
EPS 3 yr Growth
N/A
EBITDA Margin
N/A
Operating Cashflow
N/A
Free Cash Flow Return
N/A
ROIC
N/A
Interest Coverage
N/A
Quick Ratio
N/A
Shares on Issue (Fully Dilluted)
N/A
HALO Sector
Healthcare
Next Company Report Date
N/A
Ex Dividend Date (est.)
N/A
Next Dividend Pay Date (est.)
N/A
Reporting Currency
N/A
Short Sell (% of issue)
N/A
Date | Announcements |
---|---|
17 July 24 |
Jun24 Quarterly Activities Report and Appendix 4C
×
Jun24 Quarterly Activities Report and Appendix 4C |
28 June 24 |
Change in substantial holding
×
Change in substantial holding |
28 June 24 |
Cancel - Proposed issue of securities - GLH
×
Cancel - Proposed issue of securities - GLH |
28 June 24 |
Proposed issue of securities - GLH
×
Proposed issue of securities - GLH |
28 June 24 |
Notice of General Meeting
×
Notice of General Meeting |
28 June 24 |
General Meeting - Access Letter
×
General Meeting - Access Letter |
28 June 24 |
General Meeting - Sample Proxy Form
×
General Meeting - Sample Proxy Form |
20 June 24 |
Notification regarding unquoted securities - GLH
×
Notification regarding unquoted securities - GLH |
17 June 24 |
Issue of Convertible Notes
×
Issue of Convertible Notes |
17 June 24 |
Proposed issue of securities - GLH
×
Proposed issue of securities - GLH |
17 June 24 |
Proposed issue of securities - GLH
×
Proposed issue of securities - GLH |
24 April 24 |
Mar24 Quarterly Activities Report and Appendix 4C
×
Mar24 Quarterly Activities Report and Appendix 4C |
27 February 24 |
Appendix 4D and Half Year Accounts
×
Appendix 4D and Half Year Accounts |
27 February 24 |
Commentary - Half Year Accounts
×
Commentary - Half Year Accounts |
31 January 24 |
Dec23 Quarterly Activities Report and Appendix 4C
×
Dec23 Quarterly Activities Report and Appendix 4C |
21 November 23 |
2023 AGM slides
×
2023 AGM slides |
21 November 23 |
2023 AGM - MD Presentation
×
2023 AGM - MD Presentation |
21 November 23 |
Results of 2023 AGM
×
Results of 2023 AGM |
31 October 23 |
2023 Annual Report
×
2023 Annual Report |
25 October 23 |
Sep23 Quarterly Activities Report and Appendix 4C
×
Sep23 Quarterly Activities Report and Appendix 4C |
20 October 23 |
2023 AGM - Notice of Meeting
×
2023 AGM - Notice of Meeting |
20 October 23 |
2023 AGM - Chair Letter
×
2023 AGM - Chair Letter |
20 October 23 |
2023 AGM - Sample Proxy Form
×
2023 AGM - Sample Proxy Form |
16 October 23 |
Global Health signs strategic agreement with Fujitsu
×
Global Health signs strategic agreement with Fujitsu |
11 September 23 |
Adeney Private Hospital to implement Global Health platforms
×
Adeney Private Hospital to implement Global Health platforms |
Load More
Load Less
Historical data
Forecast data
Load More
Load Less
Historical data
Forecast data
Load More
Load Less
Historical data
Forecast data
Load More
Load Less
Percent of Issue
Value ($M)
Prior Change
7 Day Change
1 Month Change
3 Month Change
Access data on short interest, stock performance, and potential short-selling candidates across various markets to make informed decisions and optimize your trading strategies.
Unlock true investor intelligence
Research, trade and manage global markets from one place with HALO Global. It’s trading - the way you want it.
Get the latest insights and hot tips delivered right to your inbox
HALO Technologies Pty Ltd ABN 54 623 830 866 is a Corporate Authorised Representative No 1261916 of Macrovue Pty Ltd ABN 98 600 022 679 AFSL 484264. Macrovue Pty Ltd is a wholly owned subsidiary of HALO Technologies Pty Ltd.